Navigation Links
Eurofins MWG Operon and Queen Mary, University Of London commence genome sequencing analysis of Ash
Date:3/14/2013

Ebersberg, Germany, March 14, 2013 - Eurofins MWG Operon and School of Biological and Chemical Sciences, Queen Mary, University of London, have recently signed a cooperation agreement on the genome sequencing analysis of Ash (Fraxinus excelsior). The major aim of this project is to increase our understanding of the wide spreading fungal tree disease ash dieback (Hymenoscyphus pseudoalbidus), which is widespread in northern Europe and has already been found at more than 300 sites across the UK.

Project leader, Dr. Richard Buggs from Queen Mary's School of Biological and Chemical Sciences: "Sequencing the ash genome is a foundational step towards discovering the genetic basis of resistance to ash dieback the future of ash trees in Britain may depend on this". His research is funded by an urgency grant from the Natural Environment Research Council.

Sequencing of the approximately 900 Mb plant genome will be performed applying the latest hybrid de novo sequencing strategy, recently proven to deliver excellent scaffolding and assembly results.This new golden standard in de novo sequencing employs a combination of Roche/454 FLX++ long read technology (software version 2.8 with read lengths up to 1,100 bp) and Illumina HiSeq 2000/2500 high throughput sequencing with several ultra-accurate long jumping distance libraries (LJD of 3kb, 8kb, 20kb and 40kb), supplemented by sequencing of Illumina shotgun libraries with different fragment sizes.

The DNA samples provided by Dr. Richard Buggs, Queen Mary University of London, from tree material supplied by Earth Trust, Oxfordshire, have successfully passed the first QC steps in lab, while the Eurofins MWG Operon NGS sequencing service pipeline is already planning the first sequencing runs starting with GS FLX++.

"We take specific care that our technical and operational pipeline meets the best quality standards, fast turnaround times and the high service level we want to provide to our customers", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "Our specific library know-how fits seamlessly to this challenging and important genome sequencing project and we are confident that we will deliver excellent results."


'/>"/>

Contact: Dr. Alex Goodwin
alexgoodwin@eurofins.com
44-771-736-6379
Eurofins MWG Operon
Source:Eurekalert

Related biology news :

1. Eurofins MWG Operon reinforces NGS capability with Illumina HiSeq 2500 and Illumina MiSeq
2. Rice, MD Anderson scientists probe mystery of operon evolution
3. Researchers id queens, mysterious disease syndrome as key factors in bee colony deaths
4. Queens Diamond Jubilee Medal for obesity research expert
5. What it is to be a queen bee?
6. Queens University Belfast makes significant cancer breakthrough
7. Queens researcher finds situation dire for threatened rhino species
8. Enhanced royal jelly produces jumbo queen bee larvae
9. Queens is UK leader for female scientists and engineers
10. Life expectancy may affect when you get married, divorced, have kids: Queens University study
11. Queens scientists seek vaccine for Pseudomonas infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification ... Used combined in one project, multi-biometric solutions provide a ... ...
(Date:3/7/2017)... March 7, 2017 Brandwatch , the leading social ... The Prince,s Trust to uncover insights to support its reporting, ... The UK,s leading youth charity will be using Brandwatch ... and get a better understanding of the topics and issues that ... ...
(Date:3/2/2017)... , March 2, 2017 Summary ... to better understand Merck KGaA and its partnering interests ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and ... the partnering activity of one of the world,s leading ... are prepared upon purchase to ensure inclusion of the ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics (OTCQB: ... personalized immune therapies for solid tumor cancers, today ... million financing it announced last Friday, March 17, ... several institutional investors securities totaling 28,843,692 shares, comprised ... and 10,000,000 shares of Class C Warrants pre-funded ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology: